Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Go back to Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015| Regeneron (NASDAQ: REGN) | Delayed: 791.73 +10.24 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $781.49 | 52 Week High | $592.36 | |||
| Open | $791.98 | 52 Week Low | $325.35 | |||
| Day High | $792.63 | P/E | 207.80 | |||
| Day Low | $779.45 | EPS | $3.81 | |||
| Volume | 168,227 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.75 -0.21 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.96 | 52 Week High | $5.58 | |||
| Open | $14.61 | 52 Week Low | $3.60 | |||
| Day High | $14.76 | P/E | N/A | |||
| Day Low | $14.54 | EPS | $0.00 | |||
| Volume | 3,465,086 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.44 +0.67 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.77 | 52 Week High | $44.76 | |||
| Open | $43.70 | 52 Week Low | $36.81 | |||
| Day High | $43.74 | P/E | N/A | |||
| Day Low | $43.02 | EPS | $0.00 | |||
| Volume | 1,365,545 | |||||
